Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

World Diabetic Macular Edema Pipeline Review 2016 - Research and Markets

Research and Markets
Posted on: 25 Aug 16

Research and Markets has announced the addition of the "Diabetic Macular Edema - Pipeline Review, H2 2016" drug pipelines to their offering.

This report provides comprehensive information on the therapeutic development for Diabetic Macular Edema, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Diabetic Macular Edema and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Key Topics Covered:

  1. Introduction
  2. Diabetic Macular Edema Overview
  3. Therapeutics Development
  4. Pipeline Products for Diabetic Macular Edema - Overview
  5. Pipeline Products for Diabetic Macular Edema - Comparative Analysis
  6. Diabetic Macular Edema - Therapeutics under Development by Companies
  7. Diabetic Macular Edema - Therapeutics under Investigation by Universities/Institutes
  8. Diabetic Macular Edema Products Glance
  9. Late Stage Products
  10. Clinical Stage Products
  11. Early Stage Products
  12. Diabetic Macular Edema - Products under Development by Companies
  13. Diabetic Macular Edema - Products under Investigation by Universities/Institutes
  14. Diabetic Macular Edema - Companies Involved in Therapeutics Development (Partial List)
  • Aciont Inc.
  • ActiveSite Pharmaceuticals, Inc.
  • Adverum Biotechnologies, Inc.
  • Aerpio Therapeutics, Inc.
  • Allergan Plc
  • Ampio Pharmaceuticals, Inc.
  • Araim Pharmaceuticals, Inc.
  • Astellas Pharma Inc.
  • Boehringer Ingelheim GmbH
  • Chengdu Kanghong Pharmaceuticals

For more information about this drug pipelines visit http://www.researchandmarkets.com/research/b7vp8q/diabetic_macular

Related Topics: Cardiovascular Drugs, Optical, Endocrine and Metabolic Disorder Drugs

View source version on businesswire.com: http://www.businesswire.com/news/home/20160825006071/en/

Business Wire
www.businesswire.com

Last updated on: 25/08/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.